Flat-field imaging system and methods of use

Patent metadata

Field	Value
Publication number	US-12487163-B2
Application number	US-202418612831-A
Country	US
Kind code	B2
Filing date	Mar 21, 2024
Priority date	Jun 17, 2011
Publication date	Dec 2, 2025
Grant date	Dec 2, 2025

Abstract

A method of aligning a plurality of targets is provided. The method includes generating a plurality of targets. A third phase includes the plurality of targets. The method further includes combining a first phase, a second phase, and the third phase in a volume. The first phase, the second phase, and the third phase are substantially immiscible, and the third phase is in fluid communication with the first phase and the second phase, and the first phase, the second phase, and the third phase are operable to be in a configuration of the third phase between the first phase and the second phase in the volume.

First claim

What is claimed is:

1 . A method for analyzing targets comprising biological sample, the method comprising:
forming a volume, wherein the volume comprises a third phase in fluid communication with a first phase and a second phase and is within a field of view of an optical sensor, wherein the third phase includes a plurality of targets comprising biological sample disposed in a substantially non-overlapping single layer in the third phase within the volume, and wherein the third phase is configured to be in a position between the first and second phase forming a layer of the third phase between a layer of the first phase and a layer of the second phase within the volume; amplifying the biological sample; and imaging, using the optical sensor, the plurality of targets, to determine amplification of the biological sample.

2 . The method of claim 1 , further comprising detecting a number of targets with a positive amplification and a number of targets with a negative amplification within the plurality of targets.

3 . The method of claim 2 , further comprising quantifying an amount of biological sample within the plurality of targets.

4 . The method of claim 3 , wherein the quantifying the amount of biological sample is used for an application selected from the group consisting of: fetal diagnostics, multiplex dPCR, viral detection and quantification standards, genotyping, sequencing validation, mutation detection, detection of genetically modified organisms, rare allele detection, and copy number variation.

5 . The method of claim 1 , wherein the first phase has a first density, the second phase has a second density, and the third phase has a third density, wherein first density is heavier than the third density and the third density is heavier than the second density.

6 . The method of claim 1 , wherein the plurality of targets have substantially the same density as the third density.

7 . The method of claim 1 , wherein the first phase comprises a fluorinated fluid (HFE), and the second phase comprises a mineral oil.

8 . The method of claim 1 , wherein the plurality of targets comprises targets of a plurality of sizes.

9 . The method of claim 1 , wherein the plurality of targets comprises droplets.

10 . The method of claim 9 , further comprising agitating the volume including the first phase, second phase, and third phase to generate the plurality of droplets.

Assignees

• Life Technologies Corp

Inventors

• Andersen Mark
• Wang Haopeng
• Pallas Michael

Classifications

• C12Q1/686

  Polymerase chain reaction [PCR] · CPC title

• C12Q1/6816 Primary

  characterised by the detection means (C12Q1/6804 takes precedence) · CPC title

• G01N15/04 Primary

  Investigating sedimentation of particle suspensions · CPC title

• C12Q2565/629

  being a microfluidic device · CPC title

• C12Q2565/607

  being a sensor, e.g. electrode · CPC title